Novartis working on pan-coronavirus oral treatment, CEO says | Reuters
CEO Vas Narasimhan tells employees Novartis' deal with Trump lawyer was a mistake he's determined to overcome | Fierce Pharma
Novartis CEO Vas Narasimhan on M&a and Taking Earlier Risks on New Technology
Novartis's new chief sets sights on 'productivity revolution' | Financial Times
Novartis CEO Continues Shake-Up, Says Will Save More Than $1 Billion Annually | Barron's
The 'student' of leadership who seeks to inspire his employees | Financial Times
BSR Conference 2018 | Vasant Narasimhan | Speakers
Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on sales | Fierce Pharma
Novartis CEO Says FDA Process Could Have Been Handled Better - Bloomberg
Novartis' growth ills lay tricky treatment pathway | Reuters
Re)Focusing Big Pharma: Novartis CEO Vasant Narasimhan with Jim Cramer at Healthy Returns
Novartis CEO Sees 'Better Place' With Covid by Year-End - Bloomberg
Why Novartis CEO Vasant Narasimhan is 'un-bossing' his employees — Quartz
Novartis names Indian-origin Vasant Narasimhan as new CEO | Mint
The CEO of Novartis on Developing Drugs During a Pandemic | WIRED
Novartis CEO Vasant Narasimhan on China's coronavirus outbreak
Vasant Narasimhan to Succeed Joseph Jimenez as CEO Novartis - IndiaMedToday
Vas Narasimhan knew what to expect as Novartis CEO—or so he thought: NYT | Fierce Pharma
Novartis appointed Vasant Narasimhan as CEO, effective February 1, 2018
Novartis on Twitter: "Today we announce Vas Narasimhan as new Novartis CEO from Feb 1, 2018. Thank you 👏 Joe Jimenez for your achievements https://t.co/2VauFSX2Be https://t.co/80YIKxip4I" / Twitter
Novartis's Vas Narasimhan on AI, Data Science for Company Operations
Novartis CEO Vas Narasimhan on Culture, Strategy and Change
Watch CNBC's full interview with Novartis CEO Vas Narasimhan
